JESUS LAO: Open Payments
NPI 1275571010 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,402 in 64 payments from 12 companies in 2025. Trend: 2023 $3,061 · 2024 $1,781 · 2025 $1,402
Food & beverage: $1,402
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 16 | $301 |
| Medtronic, Inc. | 6 | $287 |
| ABBVIE INC. | 11 | $236 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $163 |
| SCILEX PHARMACEUTICALS INC. | 5 | $115 |
| Axsome Therapeutics, Inc. | 4 | $90 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $78 |
| Azurity Pharmaceuticals, Inc. | 3 | $52 |
| Boston Scientific Corporation | 1 | $26 |
| Lilly USA, LLC | 1 | $20 |
Products named: Belbuca, INTELLIS ADAPTIVESTIM, RELISTOR, UBRELVY, QULIPTA, Symbravo, ZTLido, JOURNAVX.
Industry payments across CA — which companies pay providers there.
